{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:39:41Z","timestamp":1792201181315,"version":"4.4.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182397","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:23:05Z","timestamp":1504272185000},"page":"e0182397","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":128,"title":["Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma"],"prefix":"10.1371","volume":"12","author":[{"given":"Zheling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2019ai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-9729","authenticated-orcid":true,"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/jnci\/djj295","article-title":"Breast cancer heterogeneity: a mixture of at least two main types?","volume":"98","author":"WF Anderson","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and &apos;omics","volume":"17","author":"AE McCart Reed","year":"2015","journal-title":"Breast cancer research: BCR"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2014.07.003","article-title":"Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?","volume":"92","author":"S Guiu","year":"2014","journal-title":"Critical reviews in oncology\/hematology"},{"issue":"24","key":"ref4","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1002\/cncr.29687","article-title":"The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma","volume":"121","author":"SM Wong","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1245\/s10434-014-3890-4","article-title":"Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis","volume":"22","author":"RA Nelson","year":"2015","journal-title":"Annals of surgical oncology"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2011.10.063","article-title":"Adjuvant radiation therapy and survival for pure tubular breast carcinoma\u2014experience from the SEER database","volume":"84","author":"B Li","year":"2012","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"CI Li","year":"2005","journal-title":"British journal of cancer"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X","article-title":"Changing incidence rate of invasive lobular breast carcinoma among older women","volume":"88","author":"CI Li","year":"2000","journal-title":"Cancer"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"BC Pestalozzi","year":"2008","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","article-title":"Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes","volume":"23","author":"M Cristofanilli","year":"2005","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref11","article-title":"Transcriptomic and genomic features of invasive lobular breast cancer","author":"C Desmedt","year":"2017","journal-title":"Seminars in cancer biology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer","volume":"163","author":"G Ciriello","year":"2015","journal-title":"Cell"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","article-title":"Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes","volume":"17","author":"N Wasif","year":"2010","journal-title":"Annals of surgical oncology"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","article-title":"Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period","volume":"19","author":"L Fortunato","year":"2012","journal-title":"Annals of surgical oncology"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-012-2160-z","article-title":"Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences","volume":"135","author":"AB Kwast","year":"2012","journal-title":"Breast cancer research and treatment"},{"issue":"2","key":"ref16","first-page":"53","article-title":"WHO classification of tumors of the breast, 2012","volume":"75","author":"GA Frank","year":"2013","journal-title":"Arkhiv patologii"},{"issue":"1","key":"ref17","first-page":"19","article-title":"Radiographic features of invasive lobular carcinoma of the breast","volume":"19","author":"N Uchiyama","year":"2001","journal-title":"Radiation medicine"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clinimag.2005.09.021","article-title":"Mammographic detection and staging of invasive lobular carcinoma","volume":"30","author":"J Veltman","year":"2006","journal-title":"Clinical imaging"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"EA Rakha","year":"2008","journal-title":"European journal of cancer"},{"issue":"20","key":"ref20","doi-asserted-by":"crossref","first-page":"29412","DOI":"10.18632\/oncotarget.8838","article-title":"The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches","volume":"7","author":"D Lobbezoo","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.sla.0000171306.74366.22","article-title":"Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base","volume":"242","author":"SE Singletary","year":"2005","journal-title":"Annals of surgery"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"CI Li","year":"2003","journal-title":"Jama"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10549-011-1347-z","article-title":"Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms","volume":"128","author":"J Kravchenko","year":"2011","journal-title":"Breast cancer research and treatment"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.breast.2014.01.007","article-title":"Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data","volume":"23","author":"O Brouckaert","year":"2014","journal-title":"Breast"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"e0156617","DOI":"10.1371\/journal.pone.0156617","article-title":"Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer","volume":"11","author":"D Li","year":"2016","journal-title":"PloS one"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjsurg.2006.06.020","article-title":"Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma","volume":"192","author":"TN Vo","year":"2006","journal-title":"American journal of surgery"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/ERC-06-0060","article-title":"Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment","volume":"14","author":"N Biglia","year":"2007","journal-title":"Endocrine-related cancer"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","article-title":"Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns","volume":"77","author":"X Sastre-Garau","year":"1996","journal-title":"Cancer"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1072-7515(98)00051-9","article-title":"A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes","volume":"186","author":"DJ Winchester","year":"1998","journal-title":"Journal of the American College of Surgeons"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/bjs.6042","article-title":"Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma","volume":"95","author":"JN Mhuircheartaigh","year":"2008","journal-title":"The British journal of surgery"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/B:BREA.0000021038.97593.8b","article-title":"A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast","volume":"85","author":"T Korhonen","year":"2004","journal-title":"Breast cancer research and treatment"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"G Arpino","year":"2004","journal-title":"Breast cancer research: BCR"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"DJ Dabbs","year":"2013","journal-title":"The American journal of surgical pathology"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1309\/CPUX-KWEH-7B26-YE19","article-title":"Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma","volume":"114","author":"HA Lehr","year":"2000","journal-title":"American journal of clinical pathology"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10549-011-1860-0","article-title":"Cadherin-catenin complex dissociation in lobular neoplasia of the breast","volume":"132","author":"M Morrogh","year":"2012","journal-title":"Breast cancer research and treatment"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000478-199001000-00002","article-title":"Prognosis in infiltrating lobular carcinoma. An analysis of &quot;classical&quot; and variant tumors","volume":"14","author":"D DiCostanzo","year":"1990","journal-title":"The American journal of surgical pathology"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/WHE.14.48","article-title":"Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients","volume":"10","author":"HA Azim","year":"2014","journal-title":"Women's health"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12885-016-2275-4","article-title":"Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma","volume":"16","author":"Y Adachi","year":"2016","journal-title":"BMC cancer"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.seminoncol.2008.07.005","article-title":"The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project","volume":"35","author":"DL Wickerham","year":"2008","journal-title":"Seminars in oncology"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.21071","article-title":"Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience","volume":"103","author":"RJ Santiago","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/tbj.12455","article-title":"Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival","volume":"21","author":"A Garcia-Fernandez","year":"2015","journal-title":"The breast journal"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejca.2003.08.015","article-title":"The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile","volume":"40","author":"MC Mathieu","year":"2004","journal-title":"European journal of cancer"},{"issue":"25","key":"ref43","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2015.60.8133","article-title":"Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1\u201398 Trial","volume":"33","author":"O Metzger Filho","year":"2015","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"14","key":"ref44","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1200\/JCO.2015.64.8675","article-title":"Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial","volume":"34","author":"K Ribi","year":"2016","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/annonc\/mdu544","article-title":"Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12","volume":"26","author":"M Gnant","year":"2015","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"35","key":"ref46","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2014.55.6993","article-title":"Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group","volume":"32","author":"AJ Tevaarwerk","year":"2014","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","article-title":"NCCN Guidelines Insights: Breast Cancer, Version 1.2017","volume":"15","author":"WJ Gradishar","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amjsurg.2009.06.005","article-title":"Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal\/lobular breast cancers but differ from pure invasive ductal breast cancers","volume":"198","author":"A Bharat","year":"2009","journal-title":"American journal of surgery"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1200\/JOP.2016.012914","article-title":"Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary","volume":"12","author":"HS Rugo","year":"2016","journal-title":"Journal of oncology practice"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:08:00Z","timestamp":1540339680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182397"}},"subtitle":[],"editor":[{"given":"William B.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182397","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}